0001371285-24-000128.txt : 20240515
0001371285-24-000128.hdr.sgml : 20240515
20240515192719
ACCESSION NUMBER: 0001371285-24-000128
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240507
FILED AS OF DATE: 20240515
DATE AS OF CHANGE: 20240515
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RAWLINGS DARRYL
CENTRAL INDEX KEY: 0001611679
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36537
FILM NUMBER: 24953186
MAIL ADDRESS:
STREET 1: 6100 4TH AVENUE SOUTH
STREET 2: SUITE 200
CITY: SEATTLE
STATE: WA
ZIP: 98108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRUPANION, INC.
CENTRAL INDEX KEY: 0001371285
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
ORGANIZATION NAME: 02 Finance
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6100 4TH AVENUE SOUTH
STREET 2: SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98108
BUSINESS PHONE: 888-733-2685
MAIL ADDRESS:
STREET 1: 6100 4TH AVENUE SOUTH
STREET 2: SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98108
FORMER COMPANY:
FORMER CONFORMED NAME: TRUPANION INC.
DATE OF NAME CHANGE: 20131114
FORMER COMPANY:
FORMER CONFORMED NAME: VETINSURANCE INTERNATIONAL INC
DATE OF NAME CHANGE: 20060802
4/A
1
wk-form4a_1715815625.xml
FORM 4/A
X0508
4/A
2024-05-07
2024-05-09
0
0001371285
TRUPANION, INC.
TRUP
0001611679
RAWLINGS DARRYL
C/O TRUPANION, INC.
6100 4TH AVENUE SOUTH, SUITE 200
SEATTLE
WA
98108
1
1
0
0
Chief Executive Officer
0
Common Stock
2024-05-07
4
P
0
20700
24.1383
A
614842
D
On May 9, 2024, the reporting person filed a Form 4 to report a purchase of 20,700 shares but, footnote 1 inadvertently used the word sold instead of purchased in the second and third sentences. The only change reported by this amendment is to clarify in the footnote that the reported transaction was a purchase. The proper footnote reads as follows: The reported price in Column 4, is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.46 to $24.16 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
/s/ Lauren Welsh as attorney-in-fact for Darryl Rawlings
2024-05-15